A Community-Based Epidemiologic Study of Gender Differences in the Relationship between Insulin Resistance/β-Cell Dysfunction and Diabetic Retinopathy among Type 2 Diabetic Patients in Kinmen, Taiwan
Authors:
- Jorn-Hon LiuJLJorn-Hon Liu
- Tao-Hsin TungTTTao-Hsin Tung
- Shih-Tzer TsaiSTShih-Tzer Tsai
- Pesus ChouPCPesus Chou
- Shao-Yuan ChuangSCShao-Yuan Chuang
- Shih-Jen ChenSCShih-Jen Chen
- Fenq-Lih LeeFLFenq-Lih Lee
- Hui-Chuan ShihHSHui-Chuan Shih
- Wen-Ling LiWLWen-Ling Li
- 1 June 2006
- journal article
- research article
- Published by S. Karger AG in Ophthalmologica
- Vol. 220 (4) , 252-258
Abstract
Purpose: The purpose of this study was to explore whether there were gender differences in the relation of insulin resistance and β-cell dysfunction to diabetic retinopathy among type 2 diabetic patients. Methods: From 1999 to 2002, a screening regimen for diabetic retinopathy was performed by a panel of ophthalmologists using ophthalmoscopy and 45-degree color fundus photography to examine the fundus in a total of 971 type 2 diabetic patients examined between 1991 and 1993 in Kinmen, Taiwan. Seven hundred and twenty-five type 2 diabetic patients (301 males and 424 females) attended ophthalmological fundus checkup. Results: The response rate in males and females was 71.3 and 77.2%. The proportion of diabetic retinopathy at the first eye screening was 16.3% in males and 20.1% in females. From the multiple logistic regression, the type of diabetes (known cases vs. new cases) was a significant factor of diabetic retinopathy in both males (OR = 3.65, 95% CI: 1.59–8.37) and females (OR = 3.66, 95% CI: 2.01–6.70). Diabetic retinopathy was also strongly affected by the homeostasis model assessment of insulin resistance (HOMA IR) and homeostasis model assessment of β-cell dysfunction (HOMA β-cell) (p < 0.0001 for trend test). In males, those who were in the 2nd quartile, 3rd quartile, and 4th quartile of HOMA IR had 4.87 times (95% CI: 1.18–20.11), 6.83 times (95% CI: 1.91–24.46), and 10.15 times (95% CI: 2.42–42.56) the risk for diabetic retinopathy as compared to those in the 1st quartile. There was a reduced risk for diabetic retinopathy in relation to HOMA β-cell for the 2nd quartile, 3rd quartile, and 4th quartile of 86% (95% CI: 37–97%), 95% (95% CI: 77–99%), and 96% (95% CI: 78–99%) as compared to that in the 1st quartile. Only the 4th quartile had a significant risk (OR = 2.62, 95% CI: 1.17–5.86) for diabetic retinopathy as compared to that in the 1st quartile in females. The reduced risk for diabetic retinopathy found in relation to HOMA β-cell for the 3rd and 4th quartiles were 66% (95% CI: 6–88%) and 66% (95% CI: 10–87%) as compared to that in the 1st quartile. Conclusions: Gender differences in the relationship between insulin resistance/β-cell dysfunction and diabetic retinopathy were demonstrated in type 2 diabetic patients.Keywords
This publication has 25 references indexed in Scilit:
- Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology, 2003
- Relative role of insulin resistance and β-cell dysfunction in the progression to type 2 diabetes—The Kinmen StudyDiabetes Research and Clinical Practice, 2003
- Sex steroids and insulin resistanceClinical Science, 2002
- Insulin Resistance Syndrome Predicts the Risk of Coronary Heart Disease and Stroke in Healthy Middle-Aged MenArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and ProspectsEndocrine Reviews, 1998
- A Population Survey on the Prevalence of Diabetes in Kin-Hu, KinmenDiabetes Care, 1994
- Factors Predicting Course of β-cell Function in IDDMDiabetes Care, 1992
- High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacityDiabetes Research and Clinical Practice, 1989
- The Effect of Residual Beta-cell Function on the Development of Diabetic RetinopathyDiabetic Medicine, 1986